Spotlight commentary: Changes in pharmacokinetics following significant weight loss
| المؤلف | Belančić, Andrej |
| المؤلف | Al-Sallami, Hesham S. |
| تاريخ الإتاحة | 2025-04-23T12:24:48Z |
| تاريخ النشر | 2025-03 |
| اسم المنشور | British Journal of Clinical Pharmacology |
| المعرّف | http://dx.doi.org/10.1111/bcp.16401 |
| الاقتباس | Belančić, A., & Al‐Sallami, H. S. (2025). Spotlight commentary: Changes in pharmacokinetics following significant weight loss. British Journal of Clinical Pharmacology, 91(3), 678. |
| الرقم المعياري الدولي للكتاب | 0306-5251 |
| الملخص | Obesity is associated with detrimental metabolic, mechanical and psy-chological outcomes, leading to diminished qualify of life and reducedlifespan. Whilst lifestyle modifications, including diet and physicalactivity, remain essential for managing obesity management, manypatients with obesity require additional interventions for effectivetreatment. These include anti-obesity medicines (e.g., GLP-1 receptoragonists) and/or bariatric surgery. |
| راعي المشروع | Open access publishing facilitated by University of Otago, as part of the Wiley - University of Otago agreement via the Council of Australian University Librarians. |
| اللغة | en |
| الناشر | John Wiley and Sons Inc |
| الموضوع | bariatric surgery drug dosage GLP-1 receptor agonists obesity pharmacokinetics weight loss |
| النوع | Article |
| رقم العدد | 3 |
| رقم المجلد | 91 |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث الصيدلة [1385 items ]